Results 1 to 10 of about 59,240 (301)
Medical cannabis and driving [PDF]
Australian Journal of General Practice, 2021 Medical cannabis use is increasingly common in Australia. Patients and physicians need to be aware of the important implications that such use may have for driving.The aim of this article is to briefly review the scientific evidence regarding cannabis and driving impairment and discuss current legal issues affecting patients, as well as to update ...
Arkell, Thomas R. +2 more
openaire +4 more sources
Comprehensive Psychiatry, 2020 Background: Regulatory changes are increasing access to both medical cannabis and cannabis in general. As such, understanding patterns of recreational and medical cannabis use is a high public health priority.
Jasmine Turna +5 more
doaj +3 more sources
Medical cannabis for the treatment of insomnia. [PDF]
Cochrane Database Syst RevThis is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of medical cannabis on adults with insomnia.
Varela LB +3 more
europepmc +3 more sources
Mayo Clinic Proceedings, 2018 Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United States. Clinicians are increasingly being asked by patients to share information about or certify them for medical cannabis. In order to engage in informed discussions with patients or be comfortable certifying them in states with medical ...
Jon O, Ebbert +2 more
+5 more sources
Rambam Maimonides Medical Journal, 2023 Rheumatoid diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia, are characterized by progressive inflammation in the musculoskeletal system, predominantly affecting the joints and leading to cartilage and bone damage. The resulting
Nicole Paland +5 more
doaj +1 more source
Three Decades of Cannabis Research: What are the Obstacles?
Rambam Maimonides Medical Journal, 2022 During the past few years, thousands of articles have been published concerning medical cannabis useage. Unfortunately, most publications are case studies or small and poorly designed research projects. In attempting to understand the reasons behind this
Michael Dor
doaj +1 more source
Archives of Public Health, 2022 We would like to thank authors Reece and Hulse (2022) for their three-part article titled “Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer ...
Frank Yizhao Chen +2 more
doaj +1 more source
The Immunopathology of COVID-19 and the Cannabis Paradigm
Frontiers in Immunology, 2021 Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and since then developed into a worldwide pandemic with >99 million people afflicted and >2.1 million fatal outcomes as of ...
Nicole Paland +8 more
doaj +1 more source
Medical Cannabis in Children [PDF]
Rambam Maimonides Medical Journal, 2020 The use of medical cannabis in children is rapidly growing. While robust evidence currently exists only for pure cannabidiol (CBD) to treat specific types of refractory epilepsy, in most cases, artisanal strains of CBD-rich medical cannabis are being used to treat children with various types of refractory epilepsy or irritability associated with autism
Adi Aran, Dalit Cayam-Rand
openaire +3 more sources
High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs
Frontiers in Immunology, 2022 Cytokine storm refers to the dysregulated production of inflammatory mediators leading to hyperinflammation. They are often detrimental, and worsen the severity of COVID-19 and other infectious or inflammatory diseases.
Miran Aswad +8 more
doaj +1 more source